Beacon Platform: A move to a 340B Rebate Model for Select J & J Products
TLDR; Johnson & Johnson has announced a change in its 340B program for DSH covered entities. Starting October 15th, J&J ...
Automating 340B Referral Capture: Streamlining Clinical Consult Note Collection
Conclusion and Key Findings UpfrontOur study confirmed that referral capture solutions can indeed use an automated mechanism to collect ...
How to Use Claims Scrubber Rules to Satisfy 340B Modifier Requirements
Problem: Getting the Right Modifiers on the Claims As of January 1, 2024, the Centers for Medicare & Medicaid ...
What Covered Entities Should Know About New DIR Fee Rules for Pharmacies
Some covered entities may not be aware of it, but there’s a big change starting next year for retail pharmacies ...
Patient Definition Court Ruling has Major 340B Ramifications
Earlier this month, a federal court in South Carolina issued a startling decision that could have far-reaching implications for 340B. ...
340B Modifiers Return for Medicare Part B Claims
Just when you thought you were free of them, the JG and TB 340B modifiers are back. Starting Jan. 1, ...
As 340B Contract Pharmacy Dispute Drags On, Covered Entities Need Alternatives
There is no bigger issue in 340B today than the dispute between drug manufacturers and covered entities over the role ...
Why 340B Covered Entities Should Incorporate Reporting into their Workflows
In the 340B world, talk of increased transparency and reporting are nothing new. Drug companies for years have argued there ...